Breaking News Headlines Today | Ground News

See every side of every news story

Express Pharma image

News from Express Pharma

Ground News rates Express Pharma’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, AllSides, and Media Bias/Fact Check.

Express Pharma’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Express Pharma

Where is Express Pharma located?Express Pharma's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Express Pharma News

What Putin’s Delhi Visit and India-Russia 2.0 Mean for China

Narendra Modi · Delhi

What Putin’s Delhi Visit and India-Russia 2.0 Mean for China

50% Right coverage: 4 sources

The Delhi summit positions India and Russia in testing the logic of resilience and prompts China to recalibrate accordingly See the Story

Lupin Gains USFDA Approval for New Cancer Biosimilar

Cancer · United States

Lupin Gains USFDA Approval for New Cancer Biosimilar

50% Right coverage: 4 sources

Lupin secures USFDA approval for Armlupeg, a biosimilar indicated for treating neutropenia in cancer patients. The drug, produced at Lupin’s Pune facility, offers a cost-effective alternative to Neulasta. Lupin aims to expand its biosimilar portfolio, enhancing healthcare accessibility in the US market.See the Story

Dr. Reddy’s Laboratories Targets Net-Zero Emissions by 2045 with SBTi-Approved Goals

Dr. Reddy’s Laboratories Targets Net-Zero Emissions by 2045 with SBTi-Approved Goals

Dr. Reddy’s Laboratories has announced its commitment t […] The post Dr. Reddy’s Laboratories Targets Net-Zero Emissions by 2045 with SBTi-Approved Goals first appeared on GeneOnline News. The post Dr. Reddy’s Laboratories Targets Net-Zero Emissions by 2045 with SBTi-Approved Goals appeared first on GeneOnline News.See the Story

Breaking News Topics Related to Express Pharma